ARTICLE | Company News
Five Prime, GlaxoSmithKline deal
September 22, 2014 7:00 AM UTC
GlaxoSmithKline exercised an option under a 2010 deal to gain exclusive, worldwide rights from Five Prime to develop and commercialize compounds targeting an undisclosed muscle disease target. Five Pr...